Oppositional Defiant Disorder Completed Phase 4 Trials for Dextroamphetamine (DB01576)

Also known as: Conduct Disorder / Disruptive Behavior Disorders / Disruptive behaviour disorder / Disruptive Behavior Disorder / Conduct Disorders / Behavior Disorder, Disruptive / Conduct behavior disorder / Conduct behaviour disorder / Unspecified disturbance of conduct

IndicationStatusPhase
DBCOND0032311 (Oppositional Defiant Disorder)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00228046Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity DisorderTreatment